Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Cash Flows

v3.2.0.727
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Cash flows from operating activities    
Net (loss) income $ (8,203) $ 3,735
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 253 284
Provision for doubtful accounts 29 (6)
Provision for obsolete inventory 141 6
Stock-based compensation 1,771 1,451
(Gain) loss due to change in fair value of derivative liabilities (3,164) 1,566
Impairment loss on long-term investment (See Note 3) 4,650 0
Gain on deconsolidation of Ruthigen (See Note 8) 0 (11,133)
Gain due to change in fair value of common stock (See Note 10) 0 (1,357)
Non-cash interest expense 0 863
Foreign currency transaction loss (gain) 24 (6)
(Gain) loss on disposal of property and equipment (13) 39
Changes in operating assets and liabilities:    
Accounts receivable 40 (88)
Due from affiliate 537 (537)
Inventories (627) (126)
Prepaid expenses and other current assets 162 458
Accounts payable 222 848
Accrued expenses and other liabilities (1) 271
Deferred revenue and other liabilities (2,515) (1,158)
Net cash used in operating activities (6,694) (4,890)
Cash flows from investing activities:    
Purchases of property and equipment (139) (504)
Proceeds from sale of long-term investment 963 0
Long-term deposits 51 59
Net cash provided by (used in) investing activities 875 (445)
Cash flows from financing activities:    
Proceeds from issuance of common stock and common stock purchase warrants in offerings, net of offering costs 6,785 3,188
Deferred offering costs 0 44
Proceeds from the exercise of common stock upon exercise of stock options and warrants 0 1,295
Proceeds from cash settlement liability (See Note 10) 0 33
Principal payments on long-term debt (176) (1,615)
Net cash provided by financing activities 6,609 2,945
Effect of exchange rate on cash and cash equivalents (134) (30)
Net increase (decrease) in cash and cash equivalents 656 (2,420)
Cash and cash equivalents, beginning of year 5,480 7,900
Cash and cash equivalents, end of year 6,136 5,480
Supplemental disclosure of cash flow information:    
Cash paid for interest 3 195
Non-cash operating and financing activities:    
Insurance premiums financed 116 188
Issuance of common stock to settle obligations 76 0
Non-cash investing and financing activities:    
Debt settled in connection with stock purchase agreement (See Note 10) 0 1,131
Cash settlement liability settled in connection with stock purchase agreement (See Note 10) 0 2,000
Reclassification of derivative liabilities to paid in capital 0 1,683
Warrants issued as derivative liabilities in connection with registered direct offering $ 0 $ 3,292